MolMed - Wikipedia
Meeting agenda | molmed
Molmed, Opa dei giapponesi di Agc. Per Berlusconi 30 milioni di plusvalenza - Affaritaliani.it
Relazione sulla remunerazione Molecular Medicine S.p.A.
European Population Genetic Substructure: Further Definition of Ancestry Informative Markers for Distinguishing among Diverse European Ethnic Groups | Molecular Medicine | Full Text
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY IN, INTO OR FROM ANY JURISDICTION WHER
MolMed now part of AGC Biologics | LinkedIn
Prezzi da saldo a Piazza Affari, rischio Opa straniere. Giapponesi su MolMed
MolMed now part of AGC Biologics | LinkedIn
Molmed, la giapponese Agc supera il 50% in Opa - Il Sole 24 ORE
MOLMED S.P.A. : MLM Stock Price | IT0001080248 | MarketScreener
Half-Year Financial Report at June 30th, 2020
I buy di oggi da Anima a MolMed
European Population Genetic Substructure: Further Definition of Ancestry Informative Markers for Distinguishing among Diverse European Ethnic Groups | Molecular Medicine | Full Text
Azioni MolMed: Quotazione, Andamento e Previsioni | Emanuele Perini
Molmed, opa della giapponese Agc per la biotech italiana Molmed - Wired | Wired Italia
MOLMED S.P.A.: MLM Azione Prezzo| IT0001080248 | MarketScreener
home | molmed
MolMed now part of AGC Biologics | LinkedIn
Will MolMed soon have its first Cell therapy on the Market?
Small Cap Conference 2013: listed SMEs meet investors at Borsa Italiana
MolMed now part of AGC Biologics | LinkedIn
MolMed to test the health of the European sector | Evaluate
Voluntary Tender Offer launched by AGC Inc. on all ordinary shares of MolMed: the Board of Directors approves the Issuer's not
MolMed, Fininvest aderisce all'OPA e cede quota 23,1%
COVID-19 impacting Cell&Gene therapy manufacturing Webinar | molmed
